Rating History for Enliven Therapeutics (ELVN) by Barclays

More Stocks Rated by Barclays | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/18/2026 Etzer Darout New Coverage Overweight
(N/A)		 78.00
(N/A)		 59.53
(56.38)		 -5.29% Details